AI
PBM icon

AdvisorShares Investments’s Psyence Biomedical PBM Stock Holding History

AdvisorShares Investments’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
+122,184
New +$555K 0.05% 220
2025
Q4 		– Sell
-860
Closed -$17.2K – 362
2025
Q3 		$17.2K Buy
860
+148
+21% +$4.07K ﹤0.01% 287
2025
Q2 		$23.7K Hold
712
– – ﹤0.01% 287
2025
Q1 		$21K Buy
712
+172
+32% +$10.9K ﹤0.01% 266
2024
Q4 		$56.8K Buy
540
+210
+64% +$50K 0.01% 252
2024
Q3 		$123K Buy
330
+206
+166% +$279K 0.02% 247
2024
Q2 		$148K Buy
124
+51
+70% +$153K 0.03% 237
2024
Q1 		$309K Buy
+73
New +$305K 0.05% 211

Other funds holding PBM

PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CJ
Caitlin John Brighton, Michigan $183M AUM 30.77% 1-Year Est. Return

AdvisorShares Investments's PBM Position: Q2 2026 in Review

AdvisorShares Investments opened a new position in Psyence Biomedical (PBM) in Q2 2026: 122,184 shares worth $374K. The stake represents 0.05% of the portfolio and ranks #220 among its holdings. This is a return to the name: AdvisorShares Investments previously reported a position in PBM as recently as Q3 2025.

AdvisorShares Investments first reported a position in PBM in Q1 2024 and has held it in 8 quarters since. 9 funds tracked by Wall St. Rank hold PBM as of Q2 2026.

  • AdvisorShares Investments held 122,184 shares of Psyence Biomedical worth $374K as of Q2 2026.
  • Psyence Biomedical was a new AdvisorShares Investments position in Q2 2026.
  • Psyence Biomedical made up 0.05% of AdvisorShares Investments's portfolio in Q2 2026, its #220 holding.
  • AdvisorShares Investments first reported a position in Psyence Biomedical in Q1 2024 and has held it in 8 quarters since.
  • 9 funds tracked by Wall St. Rank held Psyence Biomedical as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.